Join experts in antimicrobial agents and resistance (AAR) for a discussion on the latest issues impacting the field. Each quarter, panelists will gather for a 1-hour virtual panel discussion on a predetermined topic.

This quarterly panel is free for ASM members. Join or renew your membership today! 

Sept. 24, 2021 - Diagnostics and Carbapenems Resistance

The emergence of carbapenemases has drastically changed how clinicians and clinical microbiology laboratories perform antibiotic susceptibility testing. In this discussion, we'll review the major developments that have occurred in the clinical microbiology laboratory responding to this clinical challenge over the past 2 decades. In addition to modifying antimicrobial susceptibility testing and introducing more rapid phenotypic testing, each of the panelists will review the importance of rapid molecular diagnostics targeting carbapenemases and the use of nucleic acid sequencing technologies in the laboratory.


  • Fred C. Tenover, Ph.D. D(ABMM), F(AAM),FIDSA,FISAC, Vice President of Scientific Affairs, Cepheid. 
  • Robin Patel, M.D., D(ABMM), Elizabeth P. and Robert E. Allen Professor of Individualized Medicine, Professor of Medicine and Microbiology and Chair of the Division of Clinical Microbiology, Mayo Clinic. 
  • Romney Humphries, Ph.D., D(ABMM), M(ASCP), Professor of Pathology, Microbiology, and Immunology, Medical Director of the Microbiology Laboratory, Vanderbilt University Medical Center. 


  • Robert A. Bonomo, M.D., Associate Chief of Staff for Academic Affairs, Director, GRECC and Case VA Center for Antimicrobial Resistance and Epidemiology, Professor, Case Western Reserve University School of Medicine. 


  • Amy Mathers, M.D., D(ABMM), Associate Professor of Medicine and Pathology, Division of Infectious Disease and International Health, University of Virginia.
  • Ribhi M. Shawar, Ph.D., D(ABMM), F(AAM), Branch Chief, General Bacteriology and Antimicrobial Susceptibility Branch, Office of In Vitro Diagnostics and Radiological Health, Office of Product Evaluation and Quality Center for Devices and Radiological Health, Food and Drug Administration.
  • Maria Mojica, M.Sc., Ph.D., Postdoctoral Scholar, Division of Infectious Diseases, School of Medicine, Case Western Reserve University. 

Upcoming Sessions

  • December 2021 - History and Impact of Antimicrobial Agents and Chemotherapy (AAC)

Missed a past session?

Recordings are available free to ASM members.
View AAR Insights & Discussions Archives


You must be a current ASM member to view this content. 

Contact Information

Tamara Lake,